Literature DB >> 22682811

The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performance.

Paul E Wallner1, K Kian Ang, Anthony L Zietman, Jay R Harris, Geoffrey S Ibbott, Mary C Mahoney, Duane G Mezwa, Lynn D Wilson, Gary J Becker.   

Abstract

INTRODUCTION: In 1999, the American Board of Radiology (ABR) implemented an innovative training program track in diagnostic radiology (DR) and radiation oncology (RO) designed to stimulate development of a cadre of future academic researchers and educators in the 2 disciplines. The program was designated the Holman Research Pathway (HRP). An in-depth retrospective review of initial certification examination performance, post-training career choices, and academic productivity has not been written. This report represents a 10-year retrospective review of post-training performance of a cohort of trainees who have had sufficient time to complete their training and initial certification process and to enter practice. METHODS AND MATERIALS: All pertinent proceedings of the ABR and Accreditation Council for Graduate Medical Education (ACGME) Residency Review Committees for DR and RO between 1997 and May 2011 were reviewed. Thirty-four HRP candidates who fulfilled the established evaluation criteria were identified, and their ABR data files were analyzed regarding performance on the qualifying and certifying examinations. All candidates were contacted directly to obtain a current curriculum vitae.
RESULTS: Twenty candidates in RO and 14 candidates in DR were identifiable for review. All candidates attained initial certification. At the time of analysis, 23 of 33 (66.6%) candidates were employed in full-time academic practice (1 DR candidate remained in a fellowship and was not evaluated regarding employment status). Fifteen of 20 (75%) RO candidates were in faculty positions compared with 7 of 13 (53.8%) DR trainees. Additional academic productivity metrics are reported.
CONCLUSIONS: A high percentage of HRP trainees remained in academic practice and demonstrated significant academic productivity as measured by manuscript authorship and research support. Additional time and observation will be needed to determine whether these findings will be sustained by past, current, and future HRP trainees.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22682811     DOI: 10.1016/j.ijrobp.2012.04.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Citation-based Estimation of Scholarly Activity Among Domestic Academic Radiation Oncologists: Five-Year Update.

Authors:  Mehee Choi; Emma B Holliday; Reshma Jagsi; Lynn D Wilson; Clifton D Fuller; Charles R Thomas
Journal:  J Radiat Oncol       Date:  2014-03-01

2.  A 10-year analysis of American Society For Radiation Oncology Junior Faculty Career Development Awards.

Authors:  Randall J Kimple; Gary D Kao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-25       Impact factor: 7.038

Review 3.  Machine Learning and Radiogenomics: Lessons Learned and Future Directions.

Authors:  John Kang; Tiziana Rancati; Sangkyu Lee; Jung Hun Oh; Sarah L Kerns; Jacob G Scott; Russell Schwartz; Seyoung Kim; Barry S Rosenstein
Journal:  Front Oncol       Date:  2018-06-21       Impact factor: 6.244

4.  Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting.

Authors:  Gita Suneja; Malcolm D Mattes; Raymond B Mailhot Vega; Freddy E Escorcia; Colleen Lawton; Joel Greenberger; Aparna H Kesarwala; Alexander Spektor; Bhadrasain Vikram; Curtiland Deville; Malika Siker
Journal:  Adv Radiat Oncol       Date:  2020-05-21

5.  Clinician-Investigator Training and the Need to Pilot New Approaches to Recruiting and Retaining This Workforce.

Authors:  Alison K Hall; Sherry L Mills; P Kay Lund
Journal:  Acad Med       Date:  2017-10       Impact factor: 6.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.